[CYCC] YoY Quarter Result on 31-Dec-2005 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
23-Mar-2006
Financial Year
2005
Quarter
31-Dec-2005 [#Q4]
Profit Trend
QoQ- 71.64%
YoY- 57.25%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
Revenue 138 187 251 12 117 774 13 48.22%
PBT -3,323 -4,489 -8,181 -11,846 -6,121 -4,290 0 -
Tax -151 -152 -238 -492 -586 -5 600 -
NP -3,172 -4,337 -7,943 -11,354 -5,535 -3,586 -8,388 -14.95%
Tax Rate - - - - - - - -
Total Cost 3,310 4,524 8,194 11,366 5,652 4,360 8,401 -14.37%
Ratio Analysis
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
NP Margin -2,298.55 -2,319.25 -3,164.54 -94,616.67 -4,730.77 -463.31 -64,523.08 -42.62%
Per Share
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
EPS -115.84 -229.70 -653.10 -933.56 -511.27 -767.72 -719.14 -26.22%
EPS Diluted -114.43 -229.70 -653.10 -933.56 -511.27 -767.72 -719.14 -26.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.